Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

ONTOLOGY REPORT - ANNOTATIONS


Term:alpha-Neup5Gc-(2->8)-alpha-Neup5Gc-(2->6)-beta-D-Galp-(1->4)-D-GlcpNAc
go back to main search page
Accession:CHEBI:85890 term browser browse the term
Definition:A linear amino tetrasaccharide comprising two alpha-N-glycoloylneuraminyl residues, a beta-D-galactose residue and (at the reducing end) an N-acetyl-D-glucosamine residue, linked sequentially (2->8), (2->6) and (1->4).
Synonyms:exact_synonym: 3,5-dideoxy-5-(2-hydroxyacetamido)-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->8)-3,5-dideoxy-5-(2-hydroxyacetamido)-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->6)-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-D-glucopyranose;   3,5-dideoxy-5-(glycoloylamino)-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->8)-3,5-dideoxy-5-(glycoloylamino)-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->6)-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-D-glucopyranose
 related_synonym: Formula=C36H59N3O29;   InChI=1S/C36H59N3O29/c1-10(45)37-21-25(54)28(15(6-42)63-31(21)57)65-32-27(56)26(55)23(52)16(64-32)9-62-35(33(58)59)2-11(46)20(39-18(50)8-44)30(67-35)24(53)14(5-41)66-36(34(60)61)3-12(47)19(38-17(49)7-43)29(68-36)22(51)13(48)4-40/h11-16,19-32,40-44,46-48,51-57H,2-9H2,1H3,(H,37,45)(H,38,49)(H,39,50)(H,58,59)(H,60,61)/t11-,12-,13+,14+,15+,16+,19+,20+,21+,22+,23-,24+,25+,26-,27+,28+,29+,30+,31?,32-,35+,36+/m0/s1;   InChIKey=IAFUWLPUGUXWCB-ITKMAYAGSA-N;   N-glycoloyl-alpha-neuraminyl-(2->8)-N-glycoloyl-alpha-neuraminyl-(2->6)-beta-D-galactosyl-(1->4)-N-acetyl-D-glucosamine;   Neu5Gca2-8Neu5Gca2-6Galb1-4GlcNAc;   Neu5Gcalpha2-8Neu5Gcalpha2-6Galbeta1-4GlcNAc;   SMILES=CC(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO[C@@]3(C[C@H](O)[C@@H](NC(=O)CO)[C@@H](O3)[C@H](O)[C@@H](CO)O[C@@]3(C[C@H](O)[C@@H](NC(=O)CO)[C@@H](O3)[C@H](O)[C@H](O)CO)C(O)=O)C(O)=O)[C@H](O)[C@H](O)[C@H]2O)[C@@H]1O;   alpha-N-glycoloylneuraminyl-(2->8)-alpha-N-glycoloylneuraminyl-(2->6)-beta-D-galactosyl-(1->4)-N-acetyl-D-glucosamine;   alpha-Neu5Gc-(2->8)-alpha-Neu5Gc-(2->6)-beta-D-Gal-(1->4)-D-GlcNAc
 xref: PMID:25568069 "Europe PMC"


show annotations for term's descendants       view all columns           Sort by:
 

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 0
    chemical entity 0
      atom 0
        nonmetal atom 0
          oxygen atom 0
            oxygen molecular entity 0
              organooxygen compound 0
                carbohydrates and carbohydrate derivatives 0
                  carbohydrate derivative 0
                    oligosaccharide derivative 0
                      amino oligosaccharide 0
                        amino tetrasaccharide 0
                          alpha-Neup5Gc-(2->8)-alpha-Neup5Gc-(2->6)-beta-D-Galp-(1->4)-D-GlcpNAc 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 0
    subatomic particle 0
      composite particle 0
        hadron 0
          baryon 0
            nucleon 0
              atomic nucleus 0
                atom 0
                  main group element atom 0
                    p-block element atom 0
                      carbon group element atom 0
                        carbon atom 0
                          organic molecular entity 0
                            heteroorganic entity 0
                              organochalcogen compound 0
                                organooxygen compound 0
                                  carbohydrates and carbohydrate derivatives 0
                                    carbohydrate 0
                                      oligosaccharide 0
                                        oligosaccharide derivative 0
                                          amino oligosaccharide 0
                                            amino tetrasaccharide 0
                                              alpha-Neup5Gc-(2->8)-alpha-Neup5Gc-(2->6)-beta-D-Galp-(1->4)-D-GlcpNAc 0
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.